publication venue for
- Infant spirometry as a predictor of lung function at early childhood in cystic fibrosis patients. 2116. 2020
- Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis. 19:119-124. 2020
- The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome. 18:829-837. 2019
- Effect of freezing sputum on Pseudomonas aeruginosa population heterogeneity. 16:353-357. 2017
- Epidemic Pseudomonas aeruginosa infection in patients with cystic fibrosis is not a risk factor for poor clinical Outcomes following lung transplantation. 15:392-399. 2016
- Understanding the natural history and clinical implications of airways infections in CF — Moving beyond the classics. 15:270-271. 2016
- Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients. 14:755-762. 2015
- Alternative outcomes for the multiple breath washout in children with CF. 14:490-496. 2015
- Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients. 14:262-266. 2015
- Reduced fat oxidation rates during submaximal exercise in boys with cystic fibrosis. 13:92-98. 2014
- Inflammatory and growth factor response to continuous and intermittent exercise in youth with cystic fibrosis. 11:108-118. 2012
- Subclinical anaemia of chronic disease in adult patients with cystic fibrosis. 1:31-34. 2002